Join to view full profile
Warren G Magnuson Clinical Center, National Cancer Institute, NIH9609 Medical Center Drive, 5W-610Rockville, MD 20850
Phone+1 240-276-6142
Fax+1 240-276-7888
Dr. Zia is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Farah Zia is an oncologist based in Rockville, MD, specializing in breast cancer, gynecologic cancer, and hematologic oncology. She completed her education at George Washington University School of Medicine and Health Sciences, followed by a residency in Internal Medicine and a fellowship in Hematology and Medical Oncology at the National Institutes of Health Clinical Center. Her expertise includes clinical research, early drug development, and gynecologic malignancies. Dr. Zia has published several research articles in reputable journals, with a focus on topics like psychedelic medicines and alternative treatments in oncology. She is also involved in various clinical trials, including studies on breast and gynecologic malignancies.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2000 - 2003
George Washington UniversityResidency, Internal Medicine, 1997 - 2000- George Washington University School of Medicine and Health SciencesClass of 1997
Certifications & Licensure
MD State Medical License 2004 - 2027
VA State Medical License 1999 - 2026
DC State Medical License 1999 - 2013
American Board of Physician Specialties (ABPS) Internal Medicine
Clinical Trials
- Efficacy and Safety Study of Cediranib in Combination With Olaparib in Patients With Recurrent Platinum-Resistant Ovarian Cancer Start of enrollment: 2017 Jan 17
- Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer Start of enrollment: 2017 Feb 08
- Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies Start of enrollment: 2022 Jan 04
Publications & Presentations
PubMed
- 20 citationsAre psychedelic medicines the reset for chronic pain? Preliminary findings and research needs.Farah Z Zia, Michael H Baumann, Sean J Belouin, Robert H Dworkin, Majid H Ghauri
Neuropharmacology. 2023-08-01 - 8 citationsNational Institutes of Health psilocybin research speaker series: State of the science, regulatory and policy landscape, research gaps, and opportunities.Dan Xi, Ann Berger, David Shurtleff, Farah Z Zia, Sean Belouin
Neuropharmacology. 2023-06-01 - 22 citationsPsychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.Jack E Henningfield, Marion A Coe, Roland R Griffiths, Sean J Belouin, Ann Berger
Neuropharmacology. 2022-11-01
Press Mentions
Psychedelics Could Treat Some of the Worst Chronic Pain in the WorldMay 28th, 2024
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
